Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Jun 4, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how exercise might help improve blood vessel function in people with mental health disorders, specifically those with posttraumatic stress disorder (PTSD) and generalized anxiety disorder (GAD). The researchers want to understand how certain substances in the blood, called oxidants, can affect blood vessels in both healthy individuals and those dealing with these mental health issues.
To participate in this study, you need to be between 65 and 74 years old and generally healthy, without major heart, lung, or metabolic diseases. If you have PTSD, you'll need to meet a specific score on a questionnaire, and if you have GAD, you'll also have to meet certain score criteria. Healthy participants must have low scores on the anxiety questionnaires. Participants can expect to engage in exercise training as part of the study, helping researchers learn more about the benefits of exercise for mental health and blood vessel health. It’s important to note that certain conditions and medications may exclude you from participating, so it’s best to check if you meet the criteria before considering joining the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • apparently healthy and free of overt cardiovascular, pulmonary, or metabolic disease
- • for PTSD group, a score of ≥ 33 on PCL-5 checklist
- • for GAD group, a score of ≥ 10 on the GAD-7 self-report scale and \< 33 on the PCL-5 checklist
- • for Healthy Control group, a score of ≤ 10 on the GAD-7 self-report scale and \< 33 on the PCL-5 checklist
- Exclusion Criteria:
- • taking medications that could influence cardiovascular function
- • current smokers who have recently quit smoking
- • illicit drug use or excessive alcohol consumption
- • pregnant women
- • significant calorie restriction or vitamin/mineral deficiencies
- • limited English proficiency
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Trial Officials
Ryan Garten, PhD
Principal Investigator
Virginia Commonwealth University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials